Top compounds associated with response to CCL23


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine FIMM pan-cancer AAC -0.47 0.008
mRNA Imatinib FIMM pan-cancer AAC -0.4 0.06
mRNA Pazopanib FIMM pan-cancer AAC -0.36 0.09
mRNA BIRB 0796 FIMM pan-cancer AAC -0.36 0.1
mRNA Epothilone B FIMM pan-cancer AAC -0.34 0.09
mRNA Bosutinib FIMM pan-cancer AAC -0.32 0.3
mRNA AMG-706 FIMM pan-cancer AAC -0.3 0.1
mRNA Axitinib FIMM pan-cancer AAC -0.29 0.1
mRNA Dasatinib FIMM pan-cancer AAC -0.28 0.2
mRNA Nilotinib FIMM pan-cancer AAC -0.25 0.2
Download CSV